American Express (AXP): 34% ROE, $15.1B FCF, and a 20× P/E below Visa and Mastercard

The pick

Scope note: This is a verified qualified candidate from the current U.S.-listed-company screen and the cited peer checks. The public data pages did not expose a reproducible complete-universe export using identical ROE, FCF, and valuation definitions, so this article does not claim that AXP was the only U.S. qualifier.

Screen check

What American Express actually sells

Revenue, earnings, and cash flow

Valuation against history and peers

Balance sheet and credit health

Risks and red flags

• Credit normalization. The provision decline was helped by a reserve release, while card net write-offs still increased. Watch the 2.0% write-off rate, the 1.2% 30+ day delinquency rate, and loan growth each quarter. A sustained move above the 2.5% monitoring trigger would pressure earnings and capital at the same time. 10
• Merchant litigation and regulation. In two 2024 cases, merchants allege that AXP's anti-steering and non-discrimination provisions violate antitrust law; courts rejected motions to compel arbitration and appeals are pending. In the older Moskowitz case, a jury awarded $12.5M on one Illinois consumer-law claim, and the parties reached a settlement subject to court approval. AXP estimates a possible-loss range of $0 to $250M above accruals for disclosed proceedings, while warning that a ruling that materially increases merchant steering could affect results of operations. Monitor the First Circuit appeals and court approval of the settlement. 11
• TheFork execution. The proposed $700M cash acquisition has labor-consultation and regulatory conditions and is expected to close before year-end 2026. Watch the closing date, final consideration, and whether management gives a measurable return or expense target; the announced 75,000-venue network figure is strategic context, not an earnings forecast. 6
• Funding and capital. Debt/equity is 1.72x and cash was down 22% from year-end, even though deposits increased and CET1 stayed at 10.4%. The next hard date in the disclosed funding structure is the $6B facility's September 2028 maturity. A CET1 reading below 10% or a material rise in funding costs would change the risk/reward more than a small P/E move. 10
• Insider and short-interest signals. The current snapshot shows insider ownership of 0.12% and short interest of 2.20% of float. The public data reviewed here does not provide a clean, recent open-market insider-buying cluster; compensation awards should not be treated as bullish trading evidence. Recheck Form 4 filings before acting. 2
• Management changes. No material executive appointment or departure was identified in the current 2025 10-K and Q2 2026 filing excerpts. That is an absence of a disclosed change, not proof that no personnel movement occurred.

Catalysts and what to monitor next

1. Q3 2026 earnings — October 23, 2026, 8:30 a.m. ET. This is the next scheduled company earnings call in American Express's published calendar. The test is whether billed-business growth stays near the 9% Q2 rate while write-offs remain controlled. 12
2. TheFork closing before year-end. A successful close would extend the Membership Model into dining; delays or a higher final price would make the $700M capital allocation harder to assess. 6
3. Product refresh and spending growth. Q2 billed business grew 9%, net card fees grew 15%, and net interest income grew 11%. AXP's proposed and ongoing premium-product refreshes need to keep acquisition and retention strong without pushing credit losses higher. 7
4. Shareholder returns. The current data page shows an annualized dividend of $3.80, a 1.13% yield, four years of dividend growth in the displayed series, and a 2.49% buyback yield. The latest analyst snapshot is Buy from 30 analysts with a $374.54 average target, ranging from $315 to $450. That target is an opinion, not an underwriting assumption. 213

Verdict